Found: 26
Select item for more details and to access through your institution.
Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 3, p. 881, doi. 10.1007/s10620-020-06234-1
- By:
- Publication type:
- Article
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 10, p. 2026, doi. 10.3390/v15102026
- By:
- Publication type:
- Article
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis.
- Published in:
- Transplant International, 2002, v. 15, n. 1, p. 3, doi. 10.1111/j.1432-2277.2002.tb00090.x
- By:
- Publication type:
- Article
Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment Monitoring.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa196
- By:
- Publication type:
- Article
Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy.
- Published in:
- International Journal of Women's Health, 2019, v. 11, p. 617, doi. 10.2147/IJWH.S203022
- By:
- Publication type:
- Article
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial).
- Published in:
- Patient, 2017, v. 10, n. 5, p. 605, doi. 10.1007/s40271-017-0232-1
- By:
- Publication type:
- Article
Cutaneous Phaeohyphomycosis Caused by Veronaea bothryosa in a Liver Transplant Recipient Successfully Treated with Itraconazole.
- Published in:
- Clinical Infectious Diseases, 1999, v. 29, n. 3, p. 689, doi. 10.1086/598660
- By:
- Publication type:
- Article
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 17, p. 1736, doi. 10.1001/jama.2015.3868
- By:
- Publication type:
- Article
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 7, p. 1013, doi. 10.1093/cid/cix916
- By:
- Publication type:
- Article
Sofosbuvir-Daclatasvir-Simeprevir Plus Ribavirin in Direct-Acting Antiviral-Experienced Patients With Hepatitis C.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. 1615, doi. 10.1093/cid/cix214
- By:
- Publication type:
- Article
L'avenir radieux de l'hépatologie Première partie.
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2017, v. 24, n. 6, p. 569, doi. 10.1684/hpg.2017.1471
- By:
- Publication type:
- Article
Intrahepatic immune changes after hepatitis c virus eradication by direct‐acting antiviral therapy.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 74, doi. 10.1111/liv.14226
- By:
- Publication type:
- Article
Treatment of hepatitis C: Results in real life.
- Published in:
- Liver International, 2018, v. 38, p. 21, doi. 10.1111/liv.13638
- By:
- Publication type:
- Article
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1304, doi. 10.1111/liv.13376
- By:
- Publication type:
- Article
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1314, doi. 10.1111/liv.13383
- By:
- Publication type:
- Article
Why I do not treat patients for mild disease.
- Published in:
- Liver International, 2016, v. 36, p. 13, doi. 10.1111/liv.13019
- By:
- Publication type:
- Article
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.
- Published in:
- Liver International, 2015, v. 35, n. 7, p. 1833, doi. 10.1111/liv.12759
- By:
- Publication type:
- Article
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4.
- Published in:
- Liver International, 2015, v. 35, n. 1, p. 108, doi. 10.1111/liv.12471
- By:
- Publication type:
- Article
How to optimize HCV therapy in genotype 1 patients with cirrhosis.
- Published in:
- Liver International, 2013, v. 33, p. 46, doi. 10.1111/liv.12067
- By:
- Publication type:
- Article
Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
- Published in:
- Liver International, 2012, p. 32, doi. 10.1111/j.1478-3231.2011.02707.x
- By:
- Publication type:
- Article
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 12, p. 2029, doi. 10.1002/jmv.21583
- By:
- Publication type:
- Article
Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0145409
- By:
- Publication type:
- Article
Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145105
- By:
- Publication type:
- Article